April 5 (Reuters) - Pfizer Inc's (PFE.N), opens new tab experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing severe infections in infants when given to expecting ...
(UPDATED) Patients with bacterial or viral infections severe enough to merit hospitalization are at increased risk of experiencing a CV event compared with those who lack an infectious-disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback